Kazia Therapeutics Limited   Report issue

For profit Phase 1 Phase 2
Founded: Sydney Australia (1994)

Organization Overview

First Clinical Trial
2001
NCT00022295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kazia Therapeutics | Kazia Therapeutics Limited | Novogen Ltd